Latest Administration News

Page 114 of 136
Podium Minerals has completed its acquisition of EV Nickel’s assets, consolidating key nickel and PGM projects and welcoming industry giant Johnson Matthey as a 16.25% shareholder.
Maxwell Dee
Maxwell Dee
6 Feb 2025
InFocus Group Holdings has completed its acquisition of Bangkok-based Prodigy9, enhancing its software engineering and data analytics capabilities while aiming for rapid cash flow generation.
Sophie Babbage
Sophie Babbage
5 Feb 2025
A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.
Ada Torres
Ada Torres
5 Feb 2025
A1 Investments & Resources Ltd reported a modest cash outflow for the December quarter while actively pursuing acquisition opportunities backed by secured funding. The company aims to finalize a deal soon, contingent on shareholder and regulatory approvals.
Claire Turing
Claire Turing
4 Feb 2025
Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.
Ada Torres
Ada Torres
4 Feb 2025
Aeris Environmental has updated its quarterly cash flow report, confirming ongoing operational cash outflows but expressing confidence in maintaining current cash flow levels while exploring new funding avenues.
Maxwell Dee
Maxwell Dee
3 Feb 2025
VanEck Investments Limited has announced final dividends for a suite of its Australian and global bond ETFs, reaffirming steady income streams for investors ahead of February payments.
Claire Turing
Claire Turing
3 Feb 2025
Janus Henderson Investors has announced the final distribution for its Sustainable Credit Active ETF, delivering 18.3819 cents per unit for January 2025. Key dates for investors include the ex-date on 3 February and payment on 13 February.
Claire Turing
Claire Turing
3 Feb 2025
Alterity Therapeutics has raised over A$2 million through its U.S. ATM facility and expects nearly A$5.7 million in Australian tax rebates, fueling the advancement of its lead neurodegenerative drug candidate ATH434 following promising Phase 2 results.
Ada Torres
Ada Torres
3 Feb 2025
Ten Sixty Four Limited has revealed a staggering net loss of US$43 million for the year ended June 2024, alongside a sharp 94% revenue decline and a modified audit opinion, raising fresh questions about its financial stability.
Maxwell Dee
Maxwell Dee
3 Feb 2025
Dateline Resources Limited’s shares were suspended from ASX trading on 3 February 2025 due to a delayed periodic report, raising questions about compliance and future market activity.
Maxwell Dee
Maxwell Dee
3 Feb 2025
Rewardle Holdings Limited reported a robust net cash inflow from operating activities of $3.98 million for Q4 2024, offsetting significant investing outflows and ending the quarter with $1.23 million in cash.
Sophie Babbage
Sophie Babbage
31 Jan 2025